These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 20143154

  • 1. Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects.
    Qiu LX, Yao L, Mao C, Chen B, Zhan P, Yuan H, Xue K, Zhang J, Hu XC.
    Breast Cancer Res Treat; 2010 Sep; 123(2):543-7. PubMed ID: 20143154
    [Abstract] [Full Text] [Related]

  • 2. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
    Zhang J, Qiu LX, Wang ZH, Wu XH, Liu XJ, Wang BY, Hu XC.
    Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
    [Abstract] [Full Text] [Related]

  • 3. BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects.
    Qiu LX, Yao L, Xue K, Zhang J, Mao C, Chen B, Zhan P, Yuan H, Hu XC.
    Breast Cancer Res Treat; 2010 Sep; 123(2):487-90. PubMed ID: 20135345
    [Abstract] [Full Text] [Related]

  • 4. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.
    Qiu LX, Yao L, Mao C, Yu KD, Zhan P, Chen B, Yuan H, Zhang J, Xue K, Hu XC.
    Breast Cancer Res Treat; 2010 Jul; 122(2):521-5. PubMed ID: 20054636
    [Abstract] [Full Text] [Related]

  • 5. TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects.
    Qiu LX, Yao L, Mao C, Chen B, Zhan P, Xue K, Zhang J, Yuan H, Hu XC.
    Breast Cancer Res Treat; 2010 Sep; 123(2):563-7. PubMed ID: 20143152
    [Abstract] [Full Text] [Related]

  • 6. Association between manganese superoxide dismutase gene polymorphism and breast cancer risk: a meta-analysis of 17,842 subjects.
    Liu G, Sun G, Wang Y, Wang D, Hu W, Zhang J.
    Mol Med Rep; 2012 Oct; 6(4):797-804. PubMed ID: 22825700
    [Abstract] [Full Text] [Related]

  • 7. The association of SULT1A1 codon 213 polymorphism and breast cancer susceptibility: meta-analysis from 16 studies involving 23,445 subjects.
    Sun Y, Zang Z, Xu X, Zhang Z, Zhong L, Zan W, Zhao Y, Sun L.
    Breast Cancer Res Treat; 2011 Jan; 125(1):215-9. PubMed ID: 20505990
    [Abstract] [Full Text] [Related]

  • 8. The association between HSD17B1 Ser312Gly polymorphism and breast cancer risk: a meta-analysis including 31,053 subjects.
    Yao L, Cao LH, Qiu LX, Yu L.
    Breast Cancer Res Treat; 2010 Sep; 123(2):577-80. PubMed ID: 20151320
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.
    Yao L, Yu X, Yu L.
    Breast Cancer Res Treat; 2010 Jul; 122(2):503-7. PubMed ID: 20052535
    [Abstract] [Full Text] [Related]

  • 11. Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk - A meta-analysis.
    Wang S, Wang F, Shi X, Dai J, Peng Y, Guo X, Wang X, Shen H, Hu Z.
    Eur J Cancer; 2009 Nov; 45(16):2874-81. PubMed ID: 19467856
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis.
    Zheng W, Cong XF, Cai WH, Yang S, Mao C, Zou HW.
    Breast Cancer Res Treat; 2011 Aug; 128(3):811-5. PubMed ID: 21318603
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis.
    Yao L, Fang F, Zhong Y, Yu L.
    Breast Cancer Res Treat; 2010 Nov; 124(1):223-7. PubMed ID: 20204503
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects.
    Yu KD, Di GH, Fan L, Chen AX, Yang C, Shao ZM.
    Breast Cancer Res Treat; 2010 Jul; 122(2):483-8. PubMed ID: 20043205
    [Abstract] [Full Text] [Related]

  • 19. Relationship between polymorphism in the manganese superoxide dismutase gene and breast cancer.
    Eras-Erdogan N, Akbas E, Senli H, Kul S, Colak T.
    Mutat Res; 2009 Jul; 680(1-2):7-11. PubMed ID: 19712751
    [Abstract] [Full Text] [Related]

  • 20. Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects.
    Qiu LX, Yuan H, Yu KD, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC.
    Breast Cancer Res Treat; 2010 Jun; 121(3):703-8. PubMed ID: 19936916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.